Biologic Therapy in Head and Neck Cancer: A Road with Hurdles

Por Specenier, Pol, Vermorken, Jan B.
Publicado em 2012

Cetuximab: its unique place in head and neck cancer treatment

Por Specenier, Pol, Vermorken, Jan B
Publicado em 2013

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck

Por Szturz, Petr, Vermorken, Jan B.
Publicado no Front Oncol (2016)

CONCERT-1, an additional piece in the puzzle of (bio)-(chemo)-radiation

Por Specenier, Pol, Vermorken, Jan B.
Publicado no Ann Transl Med (2016)

A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy

Por Deschoolmeester, Vanessa, Baay, Marc, Specenier, Pol, Lardon, Filip, Vermorken, Jan B.
Publicado em 2010

Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance

Por Boeckx, Carolien, Baay, Marc, Wouters, An, Specenier, Pol, Vermorken, Jan B., Peeters, Marc, Lardon, Filip
Publicado em 2013

Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate...

Por Burtness, Barbara, Bourhis, Jean P, Vermorken, Jan B, Harrington, Kevin J, Cohen, Ezra EW
Publicado no Trials (2014)

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

Por Lardon Filip, Vermeulen Peter, Weyler Joost, Van Marck Eric, Baay Marc, Deschoolmeester Vanessa, Vermorken Jan B
Publicado em 2010-04-01

Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients

Por Deschoolmeester, Vanessa, Baay, Marc, Van Marck, Eric, Weyler, Joost, Vermeulen, Peter, Lardon, Filip, Vermorken, Jan B
Publicado em 2010

Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless?

Por Van Gestel, Dirk, De Kerf, Geert, Wouters, Kristien, Crijns, Wouter, Vermorken, Jan B., Gregoire, Vincent, Verellen, Dirk
Publicado no Radiat Oncol (2015)

In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells

Por Wouters, An, Pauwels, Bea, Lardon, Filip, Pattyn, Greet GO, Lambrechts, Hilde AJ, Baay, Marc, Meijnders, Paul, Vermorken, Jan B
Publicado em 2010

Clinical oncology in resource-limited settings

Por Buonaguro, Franco M, Gueye, Serigne N, Wabinga, Henry R, Ngoma, Twalib A, Vermorken, Jan B, Mbulaiteye, Sam M
Publicado em 2013

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

Por Huizing Manon T, Brande Jan, Weyngaert Danielle, Van Laer Carl, Weyler Joost, Specenier Pol M, Altintas Sevilay, Vermorken Jan B
Publicado em 2009-08-01

Detection of HPV and the role of p16^INK4Aoverexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer

Por Lardon Filip, Van Marck Eric, Vermeulen Peter, Weyn Christine, Baay Marc, Van Marck Veerle, Deschoolmeester Vanessa, Fontaine Veronique, Vermorken Jan B
Publicado em 2010-03-01

Detection of Microsatellite Instability in Colorectal Cancer Using an Alternative Multiplex Assay of Quasi-Monomorphic Mononucleotide Markers

Por Deschoolmeester, Vanessa, Baay, Marc, Wuyts, Wim, Van Marck, Eric, Van Damme, Nancy, Vermeulen, Peter, Lukaszuk, Krzysztof, Lardon, Filip, Vermorken, Jan B.
Publicado em 2008

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, in vitro

Por Simoens, Cindy, Lardon, Filip, Pauwels, Bea, De Pooter, Christel MJ, Lambrechts, Hilde AJ, Pattyn, Greet GO, Breillout, Fabienne, Vermorken, Jan B
Publicado em 2008

Detection of HPV and the role of p16(INK4A )overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer

Por Deschoolmeester, Vanessa, Van Marck, Veerle, Baay, Marc, Weyn, Christine, Vermeulen, Peter, Van Marck, Eric, Lardon, Filip, Fontaine, Veronique, Vermorken, Jan B
Publicado em 2010

A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck

Por Specenier, Pol M, Weyler, Joost, Van Laer, Carl, Weyngaert, Danielle Van den, Brande, Jan Van den, Huizing, Manon T, Altintas, Sevilay, Vermorken, Jan B
Publicado em 2009

Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor

Por Boeckx, Carolien, Blockx, Lina, de Beeck, Ken Op, Limame, Ridha, Camp, Guy Van, Peeters, Marc, Vermorken, Jan B, Specenier, Pol, Wouters, An, Baay, Marc, Lardon, Filip
Publicado no Am J Cancer Res (2015)

The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines

Por Pauwels, Bea, Korst, Annelies EC, Pattyn, Greet GO, Lambrechts, Hilde AJ, Kamphuis, Juliette AE, De Pooter, Christel MJ, Peters, Godefridus J, Lardon, Filip, Vermorken, Jan B
Publicado em 2006